Category: WFN1 Contributors

1 2 3 79 10 / 782 POSTS
By Brian Marckx, CFANASDAQ:BMRAREAD THE FULL BMRA RESEARCH REPORTBiomerica’s IgG Antibody Test Used to Significantly Reduce Ulcerative Colitis Symptoms, Improve QoLResults of an n=97 randomized, investigator-blinded food-exclusion study showed that B ...
By Brian Marckx, CFANASDAQ:NAOVREAD THE FULL NAOV RESEARCH REPORTZacks SCR Senior Med-Tech analyst and Director of Research Brian Marckx, CFA has initiated coverage of NanoVibronix, Inc. with a $9.00/share price target. See below for free access to h ...
By Anita Dushyanth, PhDNYSE:NNVCREAD THE FULL NNVC RESEARCH REPORTINITIATING COVERAGENanoViricides, Inc. (NYSE:NNVC) is an early stage nano-pharmaceutical company that was first listed in 2005 and became a reporting company the following year. The co ...
By David Bautz, PhDTSX:ATE.VREAD THE FULL ATE.V RESEARCH REPORTFinancial UpdateOn December 19, 2018, Antibe Therapeutics, Inc. (TSX:ATE.V) announced a warrant exercise of nearly all outstanding warrants with an expiration date in December 2018 that r ...
By Brian Marckx, CFANASDAQ:DRRXREAD THE FULL DRRX RESEARCH REPORTPipeline UpdateEarlier this week Durect (NASDAQ:DRRX) provided a corporate and pipeline update. Much of the focus was, as expected, on DUR-928. Particularly noteworthy is that the compa ...
By David Bautz, PhDNASDAQ:CFRXREAD THE FULL CFRX RESEARCH REPORTBusiness UpdateTreatment with Exebacase Beneficial to S. Aureus Bacteremia Patients On January 7, 2019, ContraFect Corp. (NASDAQ:CFRX) announced topline results from the Phase 2 trial of ...
By David Bautz, PhDNASDAQ:BCLIREAD THE FULL BCLI RESEARCH REPORTBusiness UpdateSet to Initiate Phase 2 Trial in Progressive MSOn December 17, 2018, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) announced that the U.S. Food and Drug Administration ...
what we did in Turbo Trading... bit.ly/2UQGJms @stewdomer 4h4 hours ago More Short AXGN at $20.55. Target $19...10:25 AM @stewdomer 4h4 hours ago More $KTOV we had small trade In $1.22 / OUT $1.34 no home runs today ...
By Lisa ThompsonNASDAQ:CSSEREAD THE FULL CSSE RESEARCH REPORTOn December 28, 2018, Chicken Soup for the Soul Entertainment (NASDAQ:CSSE) purchased the remaining portion of A+ it did not own from the three remaining A+ shareholders. This was comprised ...
TO REACH THE TURBO TRADING SITE GO HERE :  bit.ly/2UQGJms When I saw one of my favorite Stocktwits pundits post this ... "You should be able to make AT LEAST $1000 a week part-time, if not more with Turbo Trading and quit your day job. Many member ...
1 2 3 79 10 / 782 POSTS